These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 12527

  • 1. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ, Green AR, Boullin DJ, Grahame-Smith DG.
    Psychopharmacology (Berl); 1976 Sep 29; 49(3):287-300. PubMed ID: 12527
    [Abstract] [Full Text] [Related]

  • 2. Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats.
    Heal DJ, Green AR, Bloomfield MR, Grahame-Smith DG.
    Psychopharmacology (Berl); 1978 Apr 28; 57(2):193-7. PubMed ID: 26101
    [Abstract] [Full Text] [Related]

  • 3. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR.
    Br J Pharmacol; 1977 Feb 28; 59(2):367-71. PubMed ID: 264797
    [Abstract] [Full Text] [Related]

  • 4. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP, Grahame-Smith DG, Green AR, Tordoff AF.
    Br J Pharmacol; 1976 Feb 28; 56(2):193-9. PubMed ID: 3248
    [Abstract] [Full Text] [Related]

  • 5. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF, Green AR.
    Br J Pharmacol; 1978 Oct 28; 64(2):201-9. PubMed ID: 708990
    [Abstract] [Full Text] [Related]

  • 6. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.
    Green AR, Kelly PH.
    Br J Pharmacol; 1976 May 28; 57(1):141-7. PubMed ID: 1276533
    [Abstract] [Full Text] [Related]

  • 7. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR, Youdim MB.
    Br J Pharmacol; 1975 Nov 28; 55(3):415-22. PubMed ID: 1203627
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A, Ceresoli G, Mandelli V, Parenti M.
    J Pharmacol Exp Ther; 1990 Jun 28; 253(3):950-6. PubMed ID: 2162953
    [Abstract] [Full Text] [Related]

  • 11. The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
    Sagi Y, Driguès N, Youdim MB.
    Br J Pharmacol; 2005 Oct 28; 146(4):553-60. PubMed ID: 16086033
    [Abstract] [Full Text] [Related]

  • 12. Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms.
    Pugsley TA, Lippmann W.
    J Pharm Pharmacol; 1977 Mar 28; 29(3):135-8. PubMed ID: 15075
    [Abstract] [Full Text] [Related]

  • 13. Elevation of brain GABA concentrations with amino-oxyacetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
    Green AR, Tordoff AF, Bloomfield MR.
    J Neural Transm; 1976 Mar 28; 39(1-2):103-12. PubMed ID: 988113
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase.
    Abbracchio MP, Colombo F, Di Luca M, Zaratin P, Cattabeni F.
    Pharmacol Res Commun; 1987 Apr 28; 19(4):275-86. PubMed ID: 2889222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The contrasting actions of TRH and cycloheximide in altering the effects of centrally acting drugs: evidence for the non-involvement of dopamine sensitive adenylate cyclase.
    Green AR, Heal DJ, Grahame-Smith DG, Kelly PH.
    Neuropharmacology; 1976 Oct 28; 15(10):591-9. PubMed ID: 825788
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.